Human Stem Cell-Derived Cardiomyocytes Integrate Into the Heart of Monkeys With Right Ventricular Pressure Overload

Area of Science:

• Regenerative Medicine
• Cardiology
• Stem Cell Biology

Background:

• Cardiac ventricular pressure overload can lead to cardiac insufficiency, particularly in patients with congenital heart defects.
• Stem cell-derived cardiomyocytes are being explored as a therapeutic strategy to enhance ventricular function post-surgical repair.

Purpose of the Study:

• To assess the engraftment and integration of human induced pluripotent stem cell-derived cardiac lineage cells in a nonhuman primate model of right ventricular pressure overload.
• To evaluate the safety and efficacy of cardiomyocyte transplantation in supporting ventricular function.

Main Methods:

• Development of a novel surgical model of right ventricular pressure overload in immunosuppressed rhesus macaques.
• Intracardiac transplantation of human induced pluripotent stem cell-derived cardiac lineage cells at low and high doses.
• Monitoring of graft survival, integration, and host cardiac function via human troponin detection and histological analysis up to 12 weeks post-injection.

Main Results:

• Successful engraftment of human troponin-positive grafts was confirmed in both low-dose and high-dose treatment groups.
• Transplanted cells demonstrated progressive integration and organization, matching the host myocardium.
• Transient episodes of ventricular tachycardia were observed in some animals, with spontaneous resolution within 19 days.

Conclusions:

• Human induced pluripotent stem cell-derived cardiac lineage cells can mature and integrate into the nonhuman primate myocardium under pressure overload conditions.
• This study provides evidence for the potential of stem cell-based therapies in addressing cardiac insufficiency due to pressure overload.
• Further research is warranted to optimize cell delivery and assess long-term outcomes and safety profiles.